Companies / MRK vs VRTX
MRK vs VRTX: Merck and Vertex Pharmaceuticals
Merck (MRK) reported $65.0B in revenue against a 28.1% net margin, while Vertex Pharmaceuticals (VRTX) reported $12.0B at a 32.9% net margin, most recently.
| Metric | MRK | VRTX |
|---|---|---|
| Revenue | $65.0B | $12.0B |
| Net Income | $18.3B | $4.0B |
| Gross Margin | 74.8% | 86.2% |
| Operating Margin | — | 34.8% |
| EPS (Diluted) | $7.28 | $15.32 |
| Free Cash Flow | $12.4B | $3.2B |
| Total Debt | $49.3B | — |
| P/E Ratio | 14.5× | 29.6× |
| P/B Ratio | n/m | 6.2× |
| Stock Price | $147.90 | $542.69 |
Free: last 5 years
| Fiscal year | FY2008 🔒 | FY2009 🔒 | FY2010 🔒 | FY2011 🔒 | FY2012 🔒 | FY2013 🔒 | FY2014 🔒 | FY2015 🔒 | FY2016 🔒 | FY2017 🔒 | FY2018 🔒 | FY2019 🔒 | FY2020 🔒 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MRK Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $48.7B | $59.3B | $60.1B | $64.2B | $65.0B |
| VRTX Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $7.6B | $8.9B | $9.9B | $11.0B | $12.0B |